OCUP

Ocuphire Pharma (OCUP)

About Ocuphire Pharma (OCUP)

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.

Details

Daily high

$1.28

Daily low

$1.21

Price at open

$1.24

52 Week High

$3.40

52 Week Low

$1.15

Market cap

32.0M

Dividend yield

0.00%

Volume

1,800

Avg. volume

96,159

P/E ratio

-2.21

Ocuphire Pharma News